Centre Testing International Group (300012) Q2 2024 earnings summary

Executive summary

• Revenue for H1 2024 reached ¥2.79 billion, up 9.2% year-over-year, with net profit at ¥437.75 million, nearly flat compared to H1 2023.

• Gross margin was 49.5%, with EPS at ¥0.2606, slightly higher than last year.

• The group expanded its consolidation scope by adding 5 subsidiaries and removing 2.

Financial highlights

• Operating income: ¥2.79 billion, up from ¥2.56 billion year-over-year.

• Net profit: ¥437.75 million, compared to ¥438.76 million in H1 2023.

• Operating cash flow: -¥46,814,190, compared to ¥30,238,574 last year.

• Total assets: ¥8.59 billion at June 30, 2024.

• Total liabilities: ¥1.92 billion, equity: ¥6.67 billion.

Outlook and guidance

• Management confirmed no significant doubt on the group’s ability to continue as a going concern for the next 12 months.